CMAJ: National pharmacare program can be publicly funded through personal, corporate taxes
This CMAJ analysis suggests that most of the $9.7 billion required to fully fund a national pharmacare program should come from federal revenues. It explains that of the total cost of $23.2 billion for pharmacare, $13.5 billion could come from